Visual Restoration for Hemianopia
Status: | Recruiting |
---|---|
Healthy: | No |
Age Range: | 21 - 75 |
Updated: | 3/2/2019 |
Start Date: | March 15, 2018 |
End Date: | May 1, 2019 |
Contact: | Lisa Blanchard |
Email: | lisa_blanchard@urmc.rochester.edu |
Phone: | 585-276-5425 |
The purpose of this research is to assess the efficacy of a visual training task on reducing
the size of a visual field deficit caused by brain damage in adults, and its ability to
improve visual functions in this patient population.
the size of a visual field deficit caused by brain damage in adults, and its ability to
improve visual functions in this patient population.
Inclusion Criteria:
- Ages 21-75 years old
- Ability and willingness to sign informed consent
- Willingness to participate in both the training and evaluation sessions
- MRI or CT scan demonstrating lesion in the occipital lobe of the brain and/or
affecting white matter tracts that provide visual input to the occipital lobe of the
brain
- Brain injury due to ischemic or hemorrhagic causes that occurs after age 18 and at
least 90 days prior to screening visit
- At least two reliable HVF's demonstrating good fixation and a stable homonymous
incomplete (e.g., quadrantanopia or relative defect) or complete hemianopia
- Reliable HVFs with repeat HVFs if randomization takes place more than 4 weeks after
screening visit
- A homonymous, contiguous visual deficit measured by the 24-2 HVF to be a minimum of
two testing locations high and two testing locations wide, where impaired locations
are any that measure a threshold of less than 15 dB.
- Demonstration of good fixation on visual training task - able to fixate the small
targets presented as fixation letters reliably for 1000ms with jitter over less than 1
degree of visual angle in any direction away from target edge
Exclusion Criteria:
- Physical, neurological or mental disability that would interfere with study
intervention
- Concurrent participation in "vision therapy" other than standard occupational or
physical therapy
- Unreliable visual fields on prior testing, indicated by greater than 20% fixation
losses, false positives, or false negatives.
- Inability to discontinue medications judged to affect training and/or assessment
(e.g., Ritalin, amphetamines, dopamines, or chemotherapeutic agents)
- Physical condition likely to preclude completion of the clinical trial (e.g. end-stage
or uncontrolled cancer, uncontrolled epilepsy, or end-stage heart disease)
- Ocular or neurological condition that would interfere with training or assessment
(e.g. damage to the optic nerves or lateral geniculate nucleus, any degenerative
ocular condition)
- Best corrected vision worse than 20/40
- Impaired foveal Humphrey sensitivity as indicated by the HVF tests.
- Presence of vision loss resulting from ocular disease or disorder
- Presence of bilateral visual acuity loss from any source
- Inability to demonstrate fixation stability on eye movement monitored testing
- Inability to follow training instructions
We found this trial at
3
sites
210 Crittenden Boulevard
Rochester, New York 14642
Rochester, New York 14642
Phone: 585-276-5425
Click here to add this to my saved trials
900 Northwest 17th Street
Miami, Florida 33136
Miami, Florida 33136
Phone: 305-326-6021
Click here to add this to my saved trials
Click here to add this to my saved trials